SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Maudlin, J. K.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Infection in Solid Organ Transplantation: Prophylactic Regimens, Clinical Manifestations, and Empiric Therapy

Joanna K. Maudlin

Joanna K Maudlin, PharmD, Pharmacy Practice Resident, Department of Pharmacy, Northwestern Memorial Hospital, Superior Street and Fairbanks Court, Chicago, IL 60611

Solid organ transplantation has become an established practice for end-organ disease. Transplantation has inherent risks for infection which can be minimized by appropriate prophylactic, preemptive, and empiric antibiotic regimens. Proper vaccination and appropriate perioperative antibiotic use are of utmost importance in an immunocompromised patient. When immunosuppression is high, further prophylactic regimens against some pathogens, such as cytomegalovirus, are necessary. Empiric antibiotic therapy should be targeted to the most likely pathogens. However, certain antimicrobials may interact with immunosuppressant agents resulting in enhanced toxicity or decreasing immunosuppression. Appropriate monitoring parameters and protective measures should be taken.

Journal of Pharmacy Practice, Vol. 10, No. 2, 90-100 (1997)
DOI: 10.1177/089719009701000205


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement